
Sign up to save your podcasts
Or


In this episode, I’ll be joined by Laura Soucek, CEO of Peptomyc, a spin off company from her research lab that aims at treating cancer with anti-Myc peptides. Laura shares with us the 20-year journey she has been on to turn her breakthrough science into a drug that could change how cancer is treated. She talks about the role of profit in realising this purpose, the importance of people who say “no”, and how she has had to change to maintain progress towards her goal.
https://www.peptomyc.com/
linkedin.com/in/laurasoucek
#strategy #purpose #leadership
By Belden Menkus5
22 ratings
In this episode, I’ll be joined by Laura Soucek, CEO of Peptomyc, a spin off company from her research lab that aims at treating cancer with anti-Myc peptides. Laura shares with us the 20-year journey she has been on to turn her breakthrough science into a drug that could change how cancer is treated. She talks about the role of profit in realising this purpose, the importance of people who say “no”, and how she has had to change to maintain progress towards her goal.
https://www.peptomyc.com/
linkedin.com/in/laurasoucek
#strategy #purpose #leadership

2,561 Listeners